Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Pharmacology Research & Perspectives|May 9, 2019
Depressive disorders: Treatment failures and poor prognosis over the last 50 yearsThomas P BlackburnPharmacology, Biochemistry, and Behavior|March 13, 2002
The medical benefit of 5-HT researchBrian J Jones, Thomas P BlackburnCurrent Opinion in Pharmacology|January 29, 2003
Trace amine receptors as targets for novel therapeutics: legend, myth and factTheresa A Branchek, Thomas P BlackburnSynapse (New York, N.Y.)|March 28, 2006
The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell studyThomas P Blackburn, Katsuaki Suzuki, Charles R AshbyCurrent Opinion in Pharmacology|September 3, 2017
In memory of Norman Bowery (1944-2016)David G Trist, Terry P Kenakin, Thomas P BlackburnJournal of Internal Medicine|July 30, 2023
The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroidsTorbjörn Bäckström, Sahruh Turkmen, Roshni Das, et al.Neuroscience and Biobehavioral Reviews|April 12, 2024
Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairmentTorbjörn Bäckström, Magnus Doverskog, Thomas P Blackburn, et al.Synapse (New York, N.Y.)|November 23, 2006
Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological studyYoshimoto Sekine, Katsuaki Suzuki, P Veeraraghavan Ramachandran, et al.Synapse (New York, N.Y.)|September 27, 2002
Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell studyThomas P Blackburn, Yoshio Minabe, Derek N Middlemiss, et al.Neuropharmacology|November 7, 2025
Golexanolone affords sustained improvement of Parkinson's symptoms in rats by reducing microglia activation that restores the glutamate-GABA-dopamine pathwayMaria A Pedrosa, Gergana Mincheva, Mar Martinez-Garcia, et al.Pageof 2